Skip to main content
Top
Published in: Lung 6/2015

01-12-2015

Expression Profiles of Cytokine mRNAs in the Pleural Fluid Reveal Differences Among Tuberculosis, Malignancies, and Pneumonia-Exudative Pleural Effusions

Authors: Danillo Lucas Alves Espósito, Valdes Roberto Bollela, Ana Luisa Pereira Feitosa, Benedito Antonio Lopes da Fonseca

Published in: Lung | Issue 6/2015

Login to get access

Abstract

Introduction

Tuberculosis (TB) and malignant diseases are the most common causes of lymphocytic pleural effusion in adults. Serum and pleural fluid cytokine levels have been analyzed to help in the differential diagnosis, but with limited results.

Purpose

This study investigates transcription levels of selected cytokine genes in pleural effusion of patients under investigation for TB.

Methods

This was a prospective study that included adult patients under investigation for pleural effusion in Brazil. The expression of 19 cytokine genes was analyzed by RT-qPCR.

Results

The majority of cytokine-related genes expressed in pleural fluid of TB patients were similar in non-TB patients, except for RORA and RORC genes, which showed a statistically higher level in TB. All cytokines in the Th17 pattern were induced in TB patients’ pleural fluid. Patients with malignant pleural effusion expressed higher levels of IFN-α1, IFN-β1, TNF-α, IL-4 and IL-6, and suppression of TGFβ-1.

Conclusion

There is still a lot to understand about the cytokine roles in the pro- and anti-inflammatory environment of exudative pleural effusions. The data presented here showed an increased expression of Th17 pattern cytokines genes in TB patients that could be used as markers to differentiate tuberculous pleuritis from other common causes of exudative pleural effusion.
Literature
2.
go back to reference Sharma SK, Mitra DK, Balamurugan A et al (2002) Cytokine polarization in miliary and pleural tuberculosis. J Clin Immunol 22(6):345–352CrossRefPubMed Sharma SK, Mitra DK, Balamurugan A et al (2002) Cytokine polarization in miliary and pleural tuberculosis. J Clin Immunol 22(6):345–352CrossRefPubMed
7.
go back to reference Chen YM, Yang WK, Whang-Peng J et al (2001) An analysis of cytokine status in the serum and effusions of patients with tuberculous and lung cancer. Lung Cancer 31(1):25–30CrossRefPubMed Chen YM, Yang WK, Whang-Peng J et al (2001) An analysis of cytokine status in the serum and effusions of patients with tuberculous and lung cancer. Lung Cancer 31(1):25–30CrossRefPubMed
8.
go back to reference Seah GT, Scott GM, Rook GA (2000) Type 2 cytokine gene activation and its relationship to extent of disease in patients with tuberculosis. J Infect Dis 181(1):385–389. doi:10.1086/315200 CrossRefPubMed Seah GT, Scott GM, Rook GA (2000) Type 2 cytokine gene activation and its relationship to extent of disease in patients with tuberculosis. J Infect Dis 181(1):385–389. doi:10.​1086/​315200 CrossRefPubMed
10.
go back to reference Porcel JM, Light RW (2006) Diagnostic approach to pleural effusion in adults. Am Fam Physician 73(7):1211–1220PubMed Porcel JM, Light RW (2006) Diagnostic approach to pleural effusion in adults. Am Fam Physician 73(7):1211–1220PubMed
12.
go back to reference Bollela VR, Sato DN, Fonseca BA (1999) McFarland nephelometer as a simple method to estimate the sensitivity of the polymerase chain reaction using Mycobacterium tuberculosis as a research tool. Braz J Med Biol Res 32(9):1073–1076CrossRefPubMed Bollela VR, Sato DN, Fonseca BA (1999) McFarland nephelometer as a simple method to estimate the sensitivity of the polymerase chain reaction using Mycobacterium tuberculosis as a research tool. Braz J Med Biol Res 32(9):1073–1076CrossRefPubMed
14.
go back to reference Agnello D, Lankford CS, Bream J et al (2003) Cytokines and transcription factors that regulate T helper cell differentiation: new players and new insights. J Clin Immunol 23(3):147–161CrossRefPubMed Agnello D, Lankford CS, Bream J et al (2003) Cytokines and transcription factors that regulate T helper cell differentiation: new players and new insights. J Clin Immunol 23(3):147–161CrossRefPubMed
20.
23.
go back to reference Zhu J, Yamane H, Cote-Sierra J et al (2006) GATA-3 promotes Th2 responses through three different mechanisms: induction of Th2 cytokine production, selective growth of Th2 cells and inhibition of Th1 cell-specific factors. Cell Res 16(1):3–10. doi:10.1038/sj.cr.7310002 CrossRefPubMed Zhu J, Yamane H, Cote-Sierra J et al (2006) GATA-3 promotes Th2 responses through three different mechanisms: induction of Th2 cytokine production, selective growth of Th2 cells and inhibition of Th1 cell-specific factors. Cell Res 16(1):3–10. doi:10.​1038/​sj.​cr.​7310002 CrossRefPubMed
24.
go back to reference Roberts T, Beyers N, Aguirre A et al (2007) Immunosuppression during active tuberculosis is characterized by decreased interferon- gamma production and CD25 expression with elevated forkhead box P3, transforming growth factor-beta, and interleukin-4 mRNA levels. J Infect Dis 195(6):870–878. doi:10.1086/511277 CrossRefPubMed Roberts T, Beyers N, Aguirre A et al (2007) Immunosuppression during active tuberculosis is characterized by decreased interferon- gamma production and CD25 expression with elevated forkhead box P3, transforming growth factor-beta, and interleukin-4 mRNA levels. J Infect Dis 195(6):870–878. doi:10.​1086/​511277 CrossRefPubMed
Metadata
Title
Expression Profiles of Cytokine mRNAs in the Pleural Fluid Reveal Differences Among Tuberculosis, Malignancies, and Pneumonia-Exudative Pleural Effusions
Authors
Danillo Lucas Alves Espósito
Valdes Roberto Bollela
Ana Luisa Pereira Feitosa
Benedito Antonio Lopes da Fonseca
Publication date
01-12-2015
Publisher
Springer US
Published in
Lung / Issue 6/2015
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-015-9809-4

Other articles of this Issue 6/2015

Lung 6/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.